USP53, the gene responsible for PFIC7, was found to be related to hearing loss and hypocalcemia [51]
Treatment of diseases associated with impaired appetite regulation e.g
Its use is strictly limited to in vitro laboratory work (like cell cultures) or preclinical in vivo studies in animal models
The manufacturers in animal studies have said that there could be adverse outcomes
Conversely, the number of other PED samples increased (mean 21.1%) from 7.5% in 2020 to 32.9% in 2023
clinician determines final eligibility Who shouldn't apply: Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, history of pancreatitis, certain severe GI or kidney conditions, pregnancy, or breastfeeding - clinician screens at intake FDA regulatory status as of June 2026: Active enforcement and regulatory change ongoing